Source: Annual Congress 2009 - Cell biology of lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Prasse, M. Kolb, E. Bargagli, J. Müller-Quernheim, G. Zissel, J. Weiss, A. Renkl (Freiburg, Ulm, Germany; Siena, Italy; Hamilton, United States Of America). Key role of osteopontin in smoking-related interstitial lung diseases. Eur Respir J 2009; 34: Suppl. 53, 2854

Member's Comments

No comment yet.

Related content which might interest you: The role of macrophages in interstitial lung diseases Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017 Year: 2017 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Cellular interactions in the pathogenesis of interstitial lung diseases Source: Eur Respir Rev 2015; 24: 102-114 Year: 2015 Smoking and interstitial lung diseases Source: Eur Respir Rev 2015; 24: 428-435 Year: 2015 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Role of IL23 in the development of fibrotic interstitial lung disease Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Markers of injury and fibrosis in occupational interstitial lung diseases (OILD) Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Interstitial lung diseases and systemic disorders with lung involvement Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine Year: 2017 Interstitial lung diseases and systemic disorders with lung involvement Source: ERS Skills Course 2016 Year: 2016 Role of BALF in differential diagnosis of smoking related interstitial lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006 Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019 Biomarkers for interstitial lung disease Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease Year: 2016 The genetics of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019 Year: 2019 Serum biomarkers as prognostic factors of autoimmune pulmonary alveolar proteinosis after whole lung lavage Source: International Congress 2016 – Orphan diseases I Year: 2016 Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Looking for airways periostin in patients with interstitial lung diseases. Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018